Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial
-
* Corresponding author: Jean-Louis A Ndiaye jlndiaye@yahoo.com
Malaria Journal 2011, 10:237 doi:10.1186/1475-2875-10-237
Accesses
- Last 30 days: 69 accesses
- Last 365 days: 1620 accesses
- All time: 1620 accesses
Cited by
BioMed Central: 2 citations
|
Anupkumar R Anvikar, Bhawna Sharma, Bhartendu H Shahi, Prajesh K Tyagi, Tarit K Bose, Surya K Sharma, Prakriti Srivastava, Bina Srivastava, Jean R Kiechel, Aditya P Dash, Neena Valecha Malaria Journal 2012, 11:97 (30 March 2012) The fixed dose combination of ASAQ was found to be efficacious and safe treatment for P. falciparum malaria. The trial provides a sound basis for the use of the combination, once India opts for fixed dose combination ACT.
|
|
Bécaye Fall, Silmane Diawara, Kowry Sow, Eric Baret, Bakary Diatta, Khadidiatou B Fall, Pape S Mbaye, Fatou Fall, Yaya Diémé, Christophe Rogier, Boubacar Wade, Raymond Bercion, Bruno Pradines Malaria Journal 2011, 10:310 (20 October 2011) The paper describes a steep reduction in the prevalence of chloroquine resistant parasites and an increase in the prevalence of mefloquine resistant parasites in the Dakar region.
|